Expected Growth in Lyme Disease Treatment Market Over Next 8 Years

Lyme Disease TreatmentPR Newswire,01.15.2024, reports that according to the DelveInsight Business Research, LLP analysis, “Lyme Disease Treatment Market is Expected to Showcase Significant Growth by 2032.”  Many pharmaceutical companies are in development of preventative vaccines and novel Lyme disease drugs expected to be available commercially over the next eight years. Key companies contributing to the market increases include Pfizer, ModernaTX, Inc., Tarsus Pharmaceuticals, Inc., Valneva, Cortene, Blue Lake Biotechnology, Inovio Pharmaceuticals, Aegis Life, Abzyme Therapeutics, and others.

As Lyme disease cases continue to rise, a significant driver of this market is increased awareness about Lyme disease among the general public and medical care community. This increased awareness leads to more early diagnosis and treatment for Lyme disease cases which in turn drives the demand for improved diagnostic tests and medications/therapies with better efficacy.

For More Information:

Read the PR Newswire Article

Read more LDA Articles on Lyme Treatment